• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by UFP Technologies Inc. (Amendment)

    2/14/23 12:32:52 PM ET
    $UFPT
    Medical/Dental Instruments
    Health Care
    Get the next $UFPT alert in real time by email
    SC 13G/A 1 sc13ga_040622.htm SC 13G/A

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934

     

    (Amendment No. 21)*

     

    UFP Technologies, Inc.

    (Name of Issuer)

     

    Common Stock - $.01 Par Value

     

    902673102

    (CUSIP Number)

     

     

    December 31, 2021

    Date of Event which requires filing of this statement

     

     

    Check the appropriate box to designate the rule pursuant to which this schedule is filed:

     

     

    ☐Rule 13d-1(b)

     

    ☐Rule 13d-1(c)

     

    ☒Rule 13d-1(d)

     

     

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (the “Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

    CUSIP No. 902673102Page 2 of 5 pages

     

    SCHEDULE 13G

    Amendment No. 21

     

     

     

    1)Names of Reporting Persons; S.S. or I.R.S. Identification Nos. of Above Persons

     

      R. Jeffrey Bailly

     

    2)Check the Appropriate Box if a Member of a Group (See Instructions)

     

      (a)  

     

      (b)  

     

    3)SEC Use Only    

     

    4)Citizenship or Place of Organization   U.S.A.

     

    Number of Shares

    Beneficially Owned

    By Each Reporting

    Person With

    5) Sole Voting Power   442,516

     

    6) Shared Voting Power   0

     

    7) Sole Dispositive Power   442,516

     

    8) Shared Dispositive Power   0

     

    9)Aggregate Amount Beneficially Owned by Each Reporting Person

     

      442,516

     

    10)Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

     

       

     

    11)Percent of Class Represented by Amount in Row (9)

     

      5.9%

     

    12)Type of Reporting Person (See Instructions)

     

      IN

     

     

    CUSIP No. 902673102Page 3 of 5 pages

     

    SECURITIES AND EXCHANGE COMMISSION

    SCHEDULE 13G

    Amendment No. 21

     

    Item 1 (a)Name of Issuer: UFP Technologies, Inc.

     

      (b) Address of Issuer's Principal Executive Offices:

     

    100 Hale Street

    Newburyport, Massachusetts 01950

     

    Item 2 (a)Name of Person Filing: R. Jeffrey Bailly

     

      (b) Address of Principal Business Office or, if none, Residence:

     

    100 Hale Street

    Newburyport, Massachusetts 01950

     

      (c) Citizenship: USA

     

    (d)Title of Class of Securities: Common Stock, $.01 par value

     

      (e) CUSIP NUMBER: 902673102

     

    Item 3If this statement is filed pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:

     

      (a) [  ]  Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
      (b) [  ]  Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
      (c) [  ]  Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
      (d) [  ]  Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
      (e) [  ]  An investment advisor in accordance with §240.13d-1(b)(1)(ii)(E).
      (f) [  ]  An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F).
      (g) [  ]  A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G).
      (h) [  ]  A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
      (i) [  ]  A church plan that is excluded from the definition if an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
      (j) [  ]  Group, in accordance with §240.13d-1(b)(1)(ii)(J).

     

     

    CUSIP No. 902673102Page 4 of 5 pages

     

    Item 4 (a) Amount Beneficially Owned:

     

      (b) Percent of Class:                         5.9%

     

      (c) Number of Shares as to which such person has:

     

      (i) sole power to direct the vote 442,516  
             
      (ii) shared power to vote or to direct the vote 0  
             
      (iii) sole power to dispose or to direct the disposition of 442,516  
             
      (iv) shared power to dispose or to direct the disposition of 0  

     

    Item 5Ownership of Five Percent or Less of a Class:

     

    Not Applicable

     

    Item 6Ownership of More than Five Percent on Behalf of Another Person:

     

    Not Applicable

     

    Item 7Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company:

     

    Not Applicable

     

    Item 8Identification and Classification of Members of the Group:

     

    Not Applicable

     

    Item 9Notice of Dissolution of Group:

     

    Not Applicable

     

    Item 10Certification

     

    Not Applicable

     

     

     

    CUSIP No. 902673102Page 5 of 5 pages

     

    After reasonable inquiry and to the best of my knowledge and belief, I hereby certify that the information set forth in this statement is true, complete and correct.

     

      February 14, 2022  
      Date  
         
         
      /s/ R. Jeffrey Bailly  
      Signature  
         
         
      R. Jeffrey Bailly  
      Name/Title  

     

     

     

    Get the next $UFPT alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $UFPT

    DatePrice TargetRatingAnalyst
    3/28/2025Mkt Perform
    Raymond James
    7/17/2024$344.00 → $392.00Buy
    Lake Street
    3/20/2024Market Outperform
    CJS Securities
    2/6/2024Sector Weight
    KeyBanc Capital Markets
    12/21/2022$124.00Buy
    Lake Street
    6/22/2022$110.00Buy
    Lake Street
    11/19/2021$81.00Buy
    Colliers Securities
    More analyst ratings

    $UFPT
    SEC Filings

    View All

    SEC Form 10-Q filed by UFP Technologies Inc.

    10-Q - UFP TECHNOLOGIES INC (0000914156) (Filer)

    8/11/25 8:31:47 AM ET
    $UFPT
    Medical/Dental Instruments
    Health Care

    UFP Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - UFP TECHNOLOGIES INC (0000914156) (Filer)

    8/5/25 8:15:35 AM ET
    $UFPT
    Medical/Dental Instruments
    Health Care

    UFP Technologies Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - UFP TECHNOLOGIES INC (0000914156) (Filer)

    7/17/25 10:22:29 AM ET
    $UFPT
    Medical/Dental Instruments
    Health Care

    $UFPT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Croteau Daniel C exercised 1,318 shares at a strike of $22.36, increasing direct ownership by 55% to 3,728 units (SEC Form 4)

    4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)

    8/14/25 5:40:39 PM ET
    $UFPT
    Medical/Dental Instruments
    Health Care

    Director Hassett Joseph was granted 625 shares, increasing direct ownership by 53% to 1,800 units (SEC Form 4)

    4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)

    6/6/25 2:52:16 PM ET
    $UFPT
    Medical/Dental Instruments
    Health Care

    Director Hudson Symeria was granted 625 shares, increasing direct ownership by 118% to 1,153 units (SEC Form 4)

    4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)

    6/6/25 2:50:51 PM ET
    $UFPT
    Medical/Dental Instruments
    Health Care

    $UFPT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    UFP Technologies Announces Record Q2 Results

    NEWBURYPORT, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today reported net income of $17.2 million or $2.21 per diluted common share outstanding for its second quarter ended June 30, 2025, compared to net income of $13.6 million or $1.75 per diluted common share outstanding for the same quarter in 2024. Adjusted earnings per diluted common share outstanding grew 27% to $2.50. Sales for the second quarter were $151.2 million compared to sales of $110.2 million in the second quarter of 2024. Net income for the six-month period ended June

    8/4/25 4:15:31 PM ET
    $UFPT
    Medical/Dental Instruments
    Health Care

    UFP Technologies to Report Second Quarter 2025 Financial Results on August 4, 2025

    NEWBURYPORT, Mass., July 29, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today announced the Company plans to report financial results for the second quarter ended June 30, 2025 on August 4, 2025 after the market close. The Company will hold a conference call to discuss results the following day, August 5th, at 8:30 AM Eastern time. Conference Call Information:Date: Tuesday, August 5, 2025Time: 8:30 AM Eastern TimeParticipants may join the call using the following dial-in numbers: Toll-Free: 1-888-243-4451International: 1-412-542-4135 A live

    7/29/25 4:15:41 PM ET
    $UFPT
    Medical/Dental Instruments
    Health Care

    Trout Capital Advisors Serves as Exclusive Financial Advisor to Universal Plastics & Engineering Company in Sale to UFP Technologies

    LANCASTER, Pa., July 29, 2025 /PRNewswire/ -- Trout Capital Advisors, LLC ("TCA"), a leading lower-middle market investment banking firm, is pleased to announce it served as the exclusive financial advisor to Universal Plastics & Engineering Company, Inc. ("UNIPEC") in its sale to UFP Technologies, Inc. (NASDAQ:UFPT), a designer and manufacturer of innovative custom-engineered components, products, and solutions for the medical market. Headquartered in Rockville, Maryland, UNIPEC develops and manufactures precision thermoformed and heat-sealed polymer components used primarily for shielding batteries in Class III implantable medical devices. UNIPEC's capabilities and strong customer relatio

    7/29/25 10:05:00 AM ET
    $UFPT
    Medical/Dental Instruments
    Health Care

    $UFPT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Raymond James initiated coverage on UFP Technologies

    Raymond James initiated coverage of UFP Technologies with a rating of Mkt Perform

    3/28/25 8:21:18 AM ET
    $UFPT
    Medical/Dental Instruments
    Health Care

    Lake Street reiterated coverage on UFP Technologies with a new price target

    Lake Street reiterated coverage of UFP Technologies with a rating of Buy and set a new price target of $392.00 from $344.00 previously

    7/17/24 8:57:19 AM ET
    $UFPT
    Medical/Dental Instruments
    Health Care

    CJS Securities initiated coverage on UFP Technologies

    CJS Securities initiated coverage of UFP Technologies with a rating of Market Outperform

    3/20/24 9:43:53 AM ET
    $UFPT
    Medical/Dental Instruments
    Health Care

    $UFPT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Lataille Ronald J bought $91,636 worth of shares (400 units at $229.09), increasing direct ownership by 3% to 15,031 units (SEC Form 4)

    4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)

    2/27/25 3:57:17 PM ET
    $UFPT
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Lataille Ronald J

    4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)

    11/13/23 11:09:49 AM ET
    $UFPT
    Medical/Dental Instruments
    Health Care

    Rock Mitchell bought $27,522 worth of shares (198 units at $139.00), increasing direct ownership by 0.74% to 27,086 units (SEC Form 4)

    4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)

    11/9/23 5:21:17 PM ET
    $UFPT
    Medical/Dental Instruments
    Health Care

    $UFPT
    Leadership Updates

    Live Leadership Updates

    View All

    UFP Technologies Acquires AQF Medical

    NEWBURYPORT, Mass., Aug. 26, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products, today announced the acquisition of AQF Limited ("AQF Medical"). Headquartered in Navan, Ireland with additional joint venture operations in Singapore, AQF Medical develops and manufactures custom-engineered foam and thermoplastic components used in a wide range of medical devices and packaging. "We are excited about the addition of AQF Medical, our fourth acquisition in the past few months," said R. Jeffrey Bailly, Chairman and CEO of UFP Technologies.

    8/26/24 9:00:00 AM ET
    $UFPT
    Medical/Dental Instruments
    Health Care

    UFP Technologies Acquires Marble Medical

    NEWBURYPORT, Mass., July 16, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products, today announced the acquisition of Marble Medical. Founded in 1988 and headquartered in Tallahassee, FL, Marble Medical develops and manufactures adhesive based medical components and single-use devices. "Adding Marble Medical's adhesives expertise is a great complement to our surgical robot drapes and stick to skin device platforms," said R. Jeffrey Bailly, chairman and CEO of UFP Technologies. "Marble Medical is a 3M Preferred Converter, and along wi

    7/16/24 4:05:00 PM ET
    $UFPT
    Medical/Dental Instruments
    Health Care

    Chimerix Appoints Marc D. Kozin to Board of Directors

    DURHAM, N.C., March 21, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced the appointment of Marc D. Kozin as the newest member of the Company's Board of Directors. In addition, Patrick Machado has announced his retirement from the Chimerix Board effective at the Company's 2024 Annual Meeting of Stockholders in June, after ten years of service. "We are pleased to welcome Marc to the Board of Directors. Marc's strategic insights and leadership will undoubtedly contribute to the continued growth and success of Chimerix as we wo

    3/21/24 7:00:00 AM ET
    $CMRX
    $UFPT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical/Dental Instruments

    $UFPT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by UFP Technologies Inc.

    SC 13G - UFP TECHNOLOGIES INC (0000914156) (Subject)

    11/13/24 9:58:23 PM ET
    $UFPT
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by UFP Technologies Inc. (Amendment)

    SC 13G/A - UFP TECHNOLOGIES INC (0000914156) (Subject)

    3/8/24 3:02:25 PM ET
    $UFPT
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by UFP Technologies Inc.

    SC 13G - UFP TECHNOLOGIES INC (0000914156) (Subject)

    2/13/24 5:16:09 PM ET
    $UFPT
    Medical/Dental Instruments
    Health Care

    $UFPT
    Financials

    Live finance-specific insights

    View All

    UFP Technologies Announces Record Q2 Results

    NEWBURYPORT, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today reported net income of $17.2 million or $2.21 per diluted common share outstanding for its second quarter ended June 30, 2025, compared to net income of $13.6 million or $1.75 per diluted common share outstanding for the same quarter in 2024. Adjusted earnings per diluted common share outstanding grew 27% to $2.50. Sales for the second quarter were $151.2 million compared to sales of $110.2 million in the second quarter of 2024. Net income for the six-month period ended June

    8/4/25 4:15:31 PM ET
    $UFPT
    Medical/Dental Instruments
    Health Care

    UFP Technologies to Report Second Quarter 2025 Financial Results on August 4, 2025

    NEWBURYPORT, Mass., July 29, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today announced the Company plans to report financial results for the second quarter ended June 30, 2025 on August 4, 2025 after the market close. The Company will hold a conference call to discuss results the following day, August 5th, at 8:30 AM Eastern time. Conference Call Information:Date: Tuesday, August 5, 2025Time: 8:30 AM Eastern TimeParticipants may join the call using the following dial-in numbers: Toll-Free: 1-888-243-4451International: 1-412-542-4135 A live

    7/29/25 4:15:41 PM ET
    $UFPT
    Medical/Dental Instruments
    Health Care

    UFP Technologies Acquires UNIPEC and TPI to Expand Film and Thermoplastic Molding Capabilities

    NEWBURYPORT, Mass., July 17, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products, today announced the acquisitions of Universal Plastics & Engineering Company, Inc. ("UNIPEC") and Techno Plastics Industries, Inc. ("TPI"). These transactions further expand UFP's capabilities in tight tolerance film components and thermoplastic molding for the medical device market. UNIPEC, headquartered in Rockville, Maryland, develops and manufactures precision thermoformed and heat-sealed polymer components used primarily for shielding batteries in C

    7/17/25 9:00:00 AM ET
    $UFPT
    Medical/Dental Instruments
    Health Care